Pathogen: clinical or host-associated sample from ... - BioSample - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers: BioSample: SAMN36726479; Sample name: BWH_1249_E_col; SRA: SRS18432394

Organism: Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_1249_E_col
collected by	Brigham and Women's Hospital
collection date	2023
geographic location	USA:Boston
host	Homo sapiens
host disease	Respiratory tract infection
isolation source	tracheal aspirate
latitude and longitude	42.3362 N 71.1067 W
host age	50

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2023-07-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	==	4.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	intermediate	==	16/8	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	intermediate	==	8.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	resistant	>=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ertapenem	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	resistant	>=	8	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	susceptible	==	8/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	1/19	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN36726479
ID:: 36726479

BioProject SRA Nucleotide

Supplemental Content

Related information

BioProject
BioProject links
SRA
Links to SRA experiments
Nucleotide
Nucleotide links
Assembly
Assembly
Taxonomy
Links to Taxonomy

Recent activity

Clear Turn Off Turn On

Pathogen: clinical or host-associated sample from Escherichia coli
Pathogen: clinical or host-associated sample from Escherichia coli

biosample
Pathogen: clinical or host-associated sample from Clostridioides difficile
Pathogen: clinical or host-associated sample from Clostridioides difficile

biosample
Pathogen: clinical or host-associated sample from Pseudomonas aeruginosa
Pathogen: clinical or host-associated sample from Pseudomonas aeruginosa

biosample
Pathogen: clinical or host-associated sample from Staphylococcus aureus
Pathogen: clinical or host-associated sample from Staphylococcus aureus

biosample
Pathogen: clinical or host-associated sample from Salmonella enterica
Pathogen: clinical or host-associated sample from Salmonella enterica

biosample

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > DNA & RNA > BioSample